Ventromedial hypothalamic glucose sensing and glucose homeostasis vary throughout the estrous cycle.
17β-Estradiol (17βE) regulates glucose homeostasis in part by centrally mediated mechanisms. In female rodents, the influence of the ovarian cycle on hypoglycemia counterregulation and glucose tolerance is unclear. We found previously that in prepubertal females, 17βE modulates glucose sensing in nonadapting glucose-inhibited (GI) and adapting GI (AdGI) neurons within the ventrolateral portion of the ventromedial nucleus (VL-VMN). Nonadapting GI neurons persistently decrease their activity as glucose increases while AdGI neurons transiently respond to a glucose increase. To begin to understand if endogenous fluctuations in estrogen levels across the estrous cycle impact hypothalamic glucose sensing and glucose homeostasis, we assessed whether hypoglycemia counterregulation and glucose tolerance differed across the phases of the estrous cycle. We hypothesized that the response to insulin-induced hypoglycemia (IIH) and/or glucose tolerance would vary throughout the estrous cycle according to changes in 17βE availability. Moreover, that these changes would correlate with estrous-dependent changes in the glucose sensitivity of VL-VMN glucose-sensing neurons (GSNs).



These hypotheses were tested in female mice by measuring the response to IIH, glucose tolerance and the glucose sensitivity of VL-VMN GSNs during each phase of the estrous cycle. Furthermore, a physiological brain concentration of 17βE seen during proestrus was acutely applied to brain slices isolated on the day of diestrous and the response to low glucose in VL-VMN GSNs was assayed.



The response to IIH was strongest during diestrous. The response of nonadapting GI and AdGI neurons to a glucose decrease from 2.5 to 0.5mM also peaked during diestrous; an effect which was blunted by the addition of 17βE. In contrast, the glucose sensitivity of the subpopulation of GSNs which are excited by glucose (GE) was not affected by estrous phase or exogenous 17βE application.



These data suggest that physiological fluctuations in circulating 17βE levels across the estrous cycle lead to changes in hypothalamic glucose sensing and the response to IIH.
New Jersey Medical School, Rutgers University, 185 South Orange Ave, Newark, NJ 07103, United States. Electronic address: santiaa1@njms.rutgers.edu.
Ammy M
AM
Santiago
Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, United States. Electronic address: Deborah.Clegg@cshs.org.
Deborah J
DJ
Clegg
New Jersey Medical School, Rutgers University, 185 South Orange Ave, Newark, NJ 07103, United States. Electronic address: routhvh@njms.rutgers.edu.
Vanessa H
VH
Routh
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology; D030762:Estrous Cycle / Q000187:drug effects / Q000502:physiology*; D005215:Fasting; D005260:Female; D005947:Glucose / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D018408:Patch-Clamp Techniques; D014697:Ventromedial Hypothalamic Nucleus / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*
D001786:Blood Glucose; D007328:Insulin; D004958:Estradiol; D005947:Glucose
Estrogen; Glucose tolerance; Glucose-excited neurons; Glucose-inhibited neurons; Hypoglycemia counterregulation
Arch Med Res. 1999 Jan-Feb;30(1):19-22
10071420
Diabetes. 1995 Feb;44(2):180-4
7859938
Pflugers Arch. 1989 Sep;414(5):600-12
2780225
J Clin Endocrinol Metab. 1984 Aug;59(2):350-3
6376531
Diabetes. 2005 Jan;54(1):15-22
15616006
Cell Metab. 2011 Oct 5;14(4):453-65
21982706
J Reprod Med. 1993 Jun;38(6):417-21
8331618
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10456-60
16803960
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1012-20
17652151
Physiol Behav. 2001 Oct;74(3):399-403
11714505
Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1323-32
18812462
Mol Metab. 2016 Aug 20;5(10 ):823-33
27688996
Metabolism. 1998 Jan;47(1):121-4
9440490
J Clin Endocrinol Metab. 2010 Dec;95(12):5435-42
20843950
Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1283-7
16793940
Diabetes Care. 2004 May;27(5):1047-53
15111519
Front Neural Circuits. 2013 Oct 18;7:149
24151456
Trends Endocrinol Metab. 2015 Aug;26(8):411-21
26126705
Mol Cell Neurosci. 2014 Sep;62:30-41
25107627
Horm Metab Res. 2008 Dec;40(12):901-6
18726830
Fertil Steril. 1993 Dec;60(6):988-93
8243705
J Vis Exp. 2013 Nov 27;(81):null
24326343
Diabetes. 2007 May;56(5):1219-27
17261674
Diabetes. 2004 Aug;53(8):1959-65
15277373
Trends Endocrinol Metab. 2011 Jan;22(1):24-33
21109497
J Clin Invest. 1997 Jan 15;99(2):361-5
9006005
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2501-6
17284595
Proc Natl Sci Counc Repub China B. 1986 Apr;10(2):92-7
3749370
Pediatr Endocrinol Rev. 2011 Sep;9(1):463-73; quiz 474-5
22783644
Curr Protoc Neurosci. 2009 Jul;Appendix 4:Appendix 4I
19575469
Diabetes. 2001 Dec;50(12):2673-81
11723049
Diabetes. 2010 Feb;59(2):519-28
19934009
Am J Physiol. 1979 Sep;237(3):E214-23
382871
PLoS One. 2013 Jul 19;8(7):e68709
23894333
Diabetologia. 1993 May;36(5):460-4
8314452
Horm Metab Res. 1972 Jul;4(4):266-70
4673608
J Neurosci. 1994 Aug;14(8):5068-76
8046468
Gynecol Obstet Invest. 1998;46(3):187-90
9736801
Physiol Behav. 2010 Feb 9;99(2):175-80
19555704
Am J Physiol Cell Physiol. 2009 Apr;296(4):C746-56
19211911
Endocrinology. 1969 Jul;85(1):103-12
5815010
Nutr Diabetes. 2012 Feb 13;2:e27
23169552
Diabetes. 2003 Nov;52(11):2767-73
14578295
J Neurosci Res. 2005 Feb 1;79(3):360-7
15614787
Am J Physiol Endocrinol Metab. 2009 May;296(5):E1101-9
19223652